Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 1;75(7):2013-2014.
doi: 10.1093/jac/dkaa171.

Favipiravir, an antiviral for COVID-19?

Eric A Coomes  1 , Hourmazd Haghbayan  2   3
Affiliations

Favipiravir, an antiviral for COVID-19?

Eric A Coomes et al. J Antimicrob Chemother. .
No abstract available

PubMed Disclaimer

Comment in

  • Comment on: Favipiravir, an antiviral for COVID-19?
    Chachaima-Mar J, Pérez-Castilla J. Chachaima-Mar J, et al. J Antimicrob Chemother. 2021 Jan 1;76(1):279-280. doi: 10.1093/jac/dkaa378. J Antimicrob Chemother. 2021. PMID: 32888000 Free PMC article. No abstract available.

References

    1. Wang C, Horby PW, Hayden FG. et al. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470–3. - PMC - PubMed
    1. Furuta Y, Gowen BB, Takahashi K. et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 2013; 100: 446–54. - PMC - PubMed
    1. Wang M, Cao R, Zhang L. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30: 269–71. - PMC - PubMed
    1. Shiraki K, Daikoku T.. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 2020; 209: 107512. - PMC - PubMed
    1. Oestereich L, Ludtke A, Wurr S. et al. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 2014; 105: 17–21. - PubMed